[Vascularized composite allografts in France: An update]

Area of Science:

• Reconstructive Surgery
• Transplantation Immunology

Background:

• Vascularized composite allografts (VCAs) represent a significant advancement in reconstructive surgery, offering solutions beyond traditional methods.
• Unlike life-saving solid organ transplants, VCAs aim to enhance quality of life, but are limited by the necessity of lifelong immunosuppression.

Purpose of the Study:

• To provide an update on clinical advancements in composite tissue allografts, specifically focusing on developments in France.
• To highlight France's pioneering role and continued leadership in VCA transplantation.

Main Methods:

• Review of clinical outcomes and surgical innovations in VCA transplantation.
• Analysis of France's contributions to VCA procedures, including hand, face, uterus, and penis transplants.

Main Results:

• France has pioneered numerous VCA firsts, including unilateral and double hand, face, and uterus transplants.
• Active VCA programs in France are expanding, demonstrating significant surgical expertise and innovation.
• VCAs are recognized as a major innovation, with future reconstructive surgery expected to be heavily influenced by these procedures.

Conclusions:

• Vascularized composite allografts are transforming reconstructive possibilities and improving patient quality of life.
• France continues to lead in VCA transplantation, pushing the boundaries of surgical innovation and expanding treatment options.